GGrantIndex
← Leaderboards

Douglas F Lake

University Of Arizona

$5,263,035
Attributed
$6,392,007
Total exposure
9
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $767.4K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,392,007 · 9

By mechanism

R01$4,397,425 · 4
P01$880,648 · 1
R21$864,816 · 2
R43$243,118 · 1
R13$6,000 · 1

Top collaborators

Others in their field

Top investigators on “Proteins

Research focus

ProteinsCoccidioidomycosisProteomeCoccidioidesTranslatingRecombinantsPeptidesPreparationReportingAntigensPublishingFungusAntibodiesInfectionDiagnosisLaboratoriesSerologyDesert FeverHealth PersonnelCommunity Acquired PneumoniaAcute DiseaseEnzyme ImmunoassayComplementArea

Grant awards (28)

69th Annual Coccidioidomycosis Study Group Scientific Conference$6,000
R13 · FY2025 · AI · contact PI
Serological Biomarkers for Coccidioidomycosis$378,234
R01 · FY2024 · AI
Serological Biomarkers for Coccidioidomycosis$379,291
R01 · FY2023 · AI
A Point-of-Care Test for Rapid Diagnosis of Valley Fever$243,118
R43 · FY2023 · AI
Serological Biomarkers for Coccidioidomycosis$380,270
R01 · FY2022 · AI
Optimization of antigen preparations from Coccidioides for diagnostic testing$215,609
R21 · FY2022 · AI
Serological Biomarkers for Coccidioidomycosis$381,175
R01 · FY2021 · AI
Optimization of antigen preparations from Coccidioides for diagnostic testing$199,207
R21 · FY2021 · AI
Working Backwards from the Proteome$293,557
R01 · FY2012 · GM · contact PI
Working Backwards from the Proteome$293,713
R01 · FY2011 · GM · contact PI
Working Backwards from the Proteome$296,834
R01 · FY2010 · GM · contact PI
Working Backwards from the Proteome$299,982
R01 · FY2009 · GM · contact PI
Validation of Coccidiodes Target Antigens for Immunotherapy$175,941
P01 · FY2008 · AI · contact PI
Validation of Coccidiodes Target Antigens for Immunotherapy$174,128
P01 · FY2007 · AI · contact PI
Validation of Coccidiodes Target Antigens for Immunotherapy$178,244
P01 · FY2006 · AI · contact PI
Custon Designing Peptides for Cancer Immunotherapy$251,869
R01 · FY2005 · CA
Engineered/Proteolytic Antibodies Specific/HIV-1 gp120$224,249
R21 · FY2005 · AI
Validation of Coccidiodes Target Antigens for Immunotherapy$172,528
P01 · FY2005 · AI
Custon Designing Peptides for Cancer Immunotherapy$118,768
R01 · FY2005 · CA
Engineered/Proteolytic Antibodies Specific/HIV-1 gp120$1
R21 · FY2005 · AI
Custon Designing Peptides for Cancer Immunotherapy$251,869
R01 · FY2004 · CA
Engineered/Proteolytic Antibodies Specific/HIV-1 gp120$225,750
R21 · FY2004 · AI
Validation of Coccidiodes Target Antigens for Immunotherapy$179,807
P01 · FY2004 · AI
Custon Designing Peptides for Cancer Immunotherapy$251,869
R01 · FY2003 · CA
Custon Designing Peptides for Cancer Immunotherapy$251,869
R01 · FY2002 · CA
TCR-BINDING PEPTIDES FROM COMBINATORIAL LIBRARIES$189,375
R01 · FY2002 · AI
TCR-BINDING PEPTIDES FROM COMBINATORIAL LIBRARIES$189,375
R01 · FY2001 · AI
TCR-BINDING PEPTIDES FROM COMBINATORIAL LIBRARIES$189,375
R01 · FY2000 · AI